Kazuyuki Itoh

Osaka, 5740074, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Manipulation of the tumor microenvironment by cytokine gene transfection enhances dendritic cell-based immunotherapy.

Manipulation of the tumor microenvironment by cytokine gene transfection enhances dendritic cell-based immunotherapy.

Journal: FASEB bioAdvances

Published: June 21, 2019

Involvement of SNX1 in regulating EGFR endocytosis in a gefitinib-resistant NSCLC cell lines.

Involvement of SNX1 in regulating EGFR endocytosis in a gefitinib-resistant NSCLC cell lines.

Journal: Cancer drug resistance (Alhambra, Calif.)

Published: March 15, 2019

Evidence for intrathecal sodium butyrate as a novel option for leptomeningeal metastasis.

Evidence for intrathecal sodium butyrate as a novel option for leptomeningeal metastasis.

Journal: Journal of neuro-oncology

Published: November 04, 2017

Sodium butyrate induces senescence and inhibits the invasiveness of glioblastoma cells.

Sodium butyrate induces senescence and inhibits the invasiveness of glioblastoma cells.

Journal: Oncology letters

Published: July 19, 2017

Development of effective tumor immunotherapy using a novel dendritic cell-targeting Toll-like receptor ligand.

Development of effective tumor immunotherapy using a novel dendritic cell-targeting Toll-like receptor ligand.

Journal: PloS one

Published: July 04, 2017

Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma.

Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma.

Journal: Cancer medicine

Published: February 07, 2017

Functional and therapeutic relevance of hepatocyte growth factor/c-MET signaling in synovial sarcoma.

Functional and therapeutic relevance of hepatocyte growth factor/c-MET signaling in synovial sarcoma.

Journal: Cancer science

Published: July 09, 2016

Therapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcoma.

Therapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcoma.

Journal: BMC cancer

Published: June 07, 2016

Trabectedin is a promising antitumour agent for synovial sarcoma.

Trabectedin is a promising antitumour agent for synovial sarcoma.

Journal: Journal of chemotherapy (Florence, Italy)

Published: April 15, 2016

Daphnetin inhibits invasion and migration of LM8 murine osteosarcoma cells by decreasing RhoA and Cdc42 expression.

Daphnetin inhibits invasion and migration of LM8 murine osteosarcoma cells by decreasing RhoA and Cdc42 expression.

Journal: Biochemical and biophysical research communications

Published: January 22, 2016

Ephedrae herba stimulates hepatocyte growth factor-induced MET endocytosis and downregulation via early/late endocytic pathways in gefitinib-resistant human lung cancer cells.

Ephedrae herba stimulates hepatocyte growth factor-induced MET endocytosis and downregulation via early/late endocytic pathways in gefitinib-resistant human lung cancer cells.

Journal: International journal of oncology

Published: November 19, 2015

EGF‑stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib‑resistant human lung cancer cell line.

EGF‑stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib‑resistant human lung cancer cell line.

Journal: International journal of oncology

Published: November 13, 2014

Showing 1-12 of 22

Last Updated: 09/26/2026